CYP2S1 was significantly detected in T3 and T4 tumours, with a sequence coverage of 7% and a Mascot score of 88, while CYP20A1 was detected across pT2 and T4 tumours (Fig. 2; Table 2). This evidence concerns the gene CYP20A1 and neoplasm.